Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes?

[1]  Da-Hye Son,et al.  Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. , 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[2]  Introduction: Standards of Medical Care in Diabetes—2020 , 2019, Diabetes Care.

[3]  P. Bennett,et al.  Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. , 2019, The lancet. Diabetes & endocrinology.

[4]  Kyongyoung Kim,et al.  Insulin Resistance and the Risk of Diabetes and Dysglycemia in Korean General Adult Population , 2018, Diabetes & metabolism journal.

[5]  S. Dagogo-Jack,et al.  Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction. , 2018, Endocrinology and metabolism clinics of North America.

[6]  Frank B. Hu,et al.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications , 2018, Nature Reviews Endocrinology.

[7]  S. Poppitt,et al.  Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia , 2017, Nutrients.

[8]  A. Ghasemi,et al.  Assay-dependent variability of serum insulin concentrations: a comparison of eight assays , 2017, Scandinavian Journal of Clinical and Laboratory Investigation.

[9]  D. Khalili,et al.  Pre‐diabetes tsunami: incidence rates and risk factors of pre‐diabetes and its different phenotypes over 9 years of follow‐up , 2017, Diabetic medicine : a journal of the British Diabetic Association.

[10]  S. Dagogo-Jack,et al.  Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications , 2016, Experimental biology and medicine.

[11]  Xin Xin,et al.  Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance , 2015, Journal of diabetes research.

[12]  A. Ghasemi,et al.  Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study , 2015, Acta Diabetologica.

[13]  D. Khalili,et al.  Relationship of hyperinsulinaemia, insulin resistance and β‐cell dysfunction with incident diabetes and pre‐diabetes: the Tehran Lipid and Glucose Study , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[14]  R. Ferreira,et al.  Optimal cut-off value for homeostasis model assessment (HOMA) index of insulin-resistance in a population of patients admitted electively in a Portuguese cardiology ward. , 2014, Acta medica portuguesa.

[15]  L. Perreault,et al.  Approaching pre-diabetes. , 2014, Journal of diabetes and its complications.

[16]  G. Reaven,et al.  Evaluation of fasting plasma insulin concentration as an estimate of insulin action in nondiabetic individuals: comparison with the homeostasis model assessment of insulin resistance (HOMA-IR) , 2014, Acta Diabetologica.

[17]  Atul J. Butte,et al.  Ethnic Differences in the Relationship Between Insulin Sensitivity and Insulin Response , 2013, Diabetes Care.

[18]  P. Zimmet,et al.  The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives , 2012, Nature Reviews Endocrinology.

[19]  G. Ferns,et al.  Selection of the appropriate method for the assessment of insulin resistance , 2011, BMC medical research methodology.

[20]  S. Rhee,et al.  The Prediabetic Period: Review of Clinical Aspects , 2011, Diabetes & metabolism journal.

[21]  R. Kelishadi,et al.  Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. , 2010, Archives of Iranian medicine.

[22]  Mika Kivimäki,et al.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study , 2009, The Lancet.

[23]  F. Azizi,et al.  Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran , 2009, BMC public health.

[24]  T. Hansen,et al.  Natural History of Insulin Sensitivity and Insulin Secretion in the Progression From Normal Glucose Tolerance to Impaired Fasting Glycemia and Impaired Glucose Tolerance: The Inter99 Study , 2009, Diabetes Care.

[25]  R. Muniyappa,et al.  Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. , 2008, American journal of physiology. Endocrinology and metabolism.

[26]  J. Shaw,et al.  Insulin Sensitivity and Insulin Secretion Determined by Homeostasis Model Assessment and Risk of Diabetes in a Multiethnic Cohort of Women: the Women’s Health Initiative Observational Study , 2007, Diabetes Care.

[27]  J. Manson,et al.  Insulin Sensitivity and Insulin Secretion Determined by Homeostasis Model Assessment and Risk of Diabetes in a Multiethnic Cohort of Women , 2007, Diabetes Care.

[28]  F. Hosseinpanah,et al.  Correlation of Insulin Resistance and impaired glucose metabolism in Tehranian adults: Tehran Lipid and Glucose Study , 2006 .

[29]  Z. Bloomgarden.  Measures of insulin sensitivity. , 2006, Clinics in laboratory medicine.

[30]  H. Woerle,et al.  Different Mechanisms for Impaired Fasting Glucose and Impaired Postprandial Glucose Tolerance in Humans A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.

[31]  J. Levy,et al.  Use and abuse of HOMA modeling. , 2004, Diabetes care.

[32]  Yuichiro Yamada,et al.  Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia. , 2003, Diabetes care.

[33]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[34]  J. Shaw,et al.  Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[35]  S. Saydah,et al.  Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. , 2001, Diabetes care.

[36]  Y. Bando,et al.  The relationship of fasting plasma glucose values and other variables to 2-h postload plasma glucose in Japanese subjects. , 2001, Diabetes care.

[37]  C. Loria,et al.  Subclinical states of glucose intolerance and risk of death in the U.S. , 2001, Diabetes care.